Airway Dysfunction, Occlusions and Remodeling: COPD Patients and Mepolizumab
NCT07749001
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
36
Enrollment
OTHER
Sponsor class
Conditions
COPD (Chronic Obstructive Pulmonary Disease)
Interventions
DRUG:
Mepolizumab 100 MG Injection
Sponsor
Western University, Canada